SLC7A11 and neoplasm: The SLC7A11/GSH/GPx4 axis serves as the central defense mechanism against ferroptosis, and downregulating the expression and activity of SLC7A11 has been shown to enhance the sensitivity of tumor cells to ferroptosis (11).